MYSE CEO purchases shares and receives 225K options under equity plan
Rhea-AI Filing Summary
Darin Myman, CEO and Director of Myseum, Inc. (MYSE), reported multiple open-market purchases of common stock and a grant of stock options. The Form 4 shows three purchases on August 18, 2025 totaling 6,116 shares acquired at prices of $1.93, $1.9132 and $2.15, bringing his direct beneficial ownership to 182,516 shares after the transactions. On the same date he was granted options to purchase 225,000 shares at an exercise price of $3.00 that vest in four equal semiannual installments beginning six months after issuance and expire August 18, 2030. The filing notes indirect beneficial ownership of shares held by his spouse and includes a disclaimer of beneficial ownership by the reporting person.
Positive
- Insider purchases recorded: Reporting person acquired a total of 6,116 shares on August 18, 2025, increasing direct ownership to 182,516 shares.
- Equity incentive alignment: Grant of 225,000 options with a multi-period vesting schedule aligns CEO incentives with long-term performance.
- Transparent disclosure: Filing discloses indirect ownership by spouse and includes standard disclaimer, meeting Section 16 reporting requirements.
Negative
- Potential dilution: Options to purchase 225,000 shares at $3.00 could dilute existing shareholders if fully exercised.
- Exercise price above recent trades: Option exercise price of $3.00 exceeds the reported purchase prices (~$1.91–$2.15), meaning options are currently out-of-the-money and may not provide immediate intrinsic value.
Insights
TL;DR: Insider purchases plus a sizable option grant show management participation and future equity dilution potential.
The reporting shows both current purchases of common stock and a contemporaneous option grant of 225,000 shares exercisable at $3.00 through 2030. The purchases (6,116 shares across three trades) increase direct holdings to 182,516 shares, and the option grant creates potential future issuance if exercised. From a securities standpoint, the combination of purchases and incentive awards indicates alignment of the CEO with equity ownership while also introducing potential dilution if options vest and are exercised.
TL;DR: Standard Section 16 disclosure of insider activity and equity incentive grant; vesting schedule aligns retention with multi-year service.
The Form 4 discloses a routine equity incentive grant under the companys 2021 Equity Incentive Plan with a clear vesting schedule (four equal semiannual installments beginning six months after issuance). The filing also records personal open-market purchases and notes indirect ownership by spouse, satisfying disclosure obligations. The report includes the reporting person's disclaimer of beneficial ownership, a common legal precaution. No governance red flags are explicitly disclosed in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options (right to buy) | 225,000 | $0.00 | -- |
| Purchase | Common Stock | 616 | $1.93 | $1K |
| Purchase | Common Stock | 3,000 | $1.9132 | $6K |
| Purchase | Common Stock | 2,500 | $2.15 | $5K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 225,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance.
FAQ
What transactions did Darin Myman report for Myseum, Inc. (MYSE)?
What are the key terms of the option grant disclosed on the Form 4?
Does the filing indicate any indirect ownership?
Did the reporting person disclaim beneficial ownership?